AdaptHealth Corp. beat EPS estimates 50% of the time across 16 reported quarters (8 beats, 8 misses), averaging -4.7% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | not reported | $0.03 | not reported | not reported | |
| Q1 FY26 | not reported | $-0.10 | not reported | not reported | Q1 FY26 call |
| Q4 FY25 | $0.30 | $0.23 | -23.3% | Miss | |
| Q3 FY25 | $0.22 | $0.19 | -13.6% | Miss | |
| Q2 FY25 | not reported | $-0.03 | not reported | not reported | |
| Q1 FY25 | $-0.02 | $-0.02 | +0.0% | Beat | |
| Q4 FY24 | $0.27 | $0.37 | +37.0% | Beat | |
| Q3 FY24 | $0.17 | $0.20 | +17.6% | Beat | |
| Q2 FY24 | $0.14 | $0.18 | +28.6% | Beat | |
| Q1 FY24 | not reported | $0.02 | not reported | not reported | |
| Q4 FY23 | not reported | $0.64 | not reported | not reported | |
| Q3 FY23 | $0.19 | $0.19 | +0.0% | Beat |
Back to AHCO overview · AHCO holders · AHCO KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.